Vibration perception threshold--a valuable assessment of neural dysfunction in people with diabetes (Q36495350)

14 August 2017

1 reference

title

Vibration perception threshold--a valuable assessment of neural dysfunction in people with diabetes (English)

1 reference

14 August 2017

Adam P Garrow

1

1 reference

PubMed ID

16741996

14 August 2017

Andrew J M Boulton

series ordinal

2

1 reference

14 August 2017

1 September 2006

1 reference

Diabetes - Metabolism: Research and Reviews

14 August 2017

1 reference

14 August 2017

22

1 reference

14 August 2017

5

1 reference

14 August 2017

411-419

1 reference

Quantitative sensory testing

14 August 2017

1 reference

Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation

21 January 2018

1 reference

A prospective study of predictors for foot ulceration in type 2 diabetes

21 January 2018

1 reference

Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology

21 January 2018

1 reference

7 January 2021

Diabetic somatic neuropathies

1 reference

7 January 2021

The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument.

1 reference

7 January 2021

Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings

1 reference

7 January 2021

Diabetic neuropathies: a statement by the American Diabetes Association

1 reference

7 January 2021

The natural history of diabetic peripheral neuropathy determined by a 12 year prospective study using vibration perception thresholds

1 reference

7 January 2021

A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population

1 reference

7 January 2021

The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort.

1 reference

7 January 2021

Methods for assessing diabetic polyneuropathy: validity and reproducibility of the measurement of sensory symptom severity and nerve function tests

1 reference

7 January 2021

Clinical practice. Neuropathic diabetic foot ulcers

1 reference

7 January 2021

Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration

1 reference

7 January 2021

Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial

1 reference

7 January 2021

Incidence, outcomes, and cost of foot ulcers in patients with diabetes.

1 reference

7 January 2021

Potential economic benefits of lower-extremity amputation prevention strategies in diabetes

1 reference

7 January 2021

A foot care program for diabetic unilateral lower-limb amputees.

1 reference

7 January 2021

Health-economic consequences of diabetic foot lesions

1 reference

7 January 2021

Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy

1 reference

7 January 2021

New developments in the diagnosis of diabetic neuropathy

1 reference

7 January 2021

Simple screening tests for peripheral neuropathy in the diabetes clinic.

1 reference

7 January 2021

Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy

1 reference

7 January 2021

Sural nerve pathology in diabetic patients with minimal but progressive neuropathy

1 reference

7 January 2021

Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration

1 reference

7 January 2021

Vibratory perception in diabetics; a biothesiometric study

1 reference

7 January 2021

Vibration perception threshold testing in patients with diabetic neuropathy: ceiling effects and reliability

1 reference

7 January 2021

Comparison of a neurothesiometer and vibration in measuring vibration perception thresholds and relationship to nerve conduction studies

1 reference

7 January 2021

Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

7 January 2021

The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study

1 reference

7 January 2021

Vibration Perception Threshold: Influence of Age, Height, Sex, and Smoking, and Calculation of Accurate Centile Values

1 reference

7 January 2021

Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic.

1 reference

7 January 2021

A case of hand ulceration in the diabetic foot clinic--a reminder of hand neuropathy in 'at risk' patients.

1 reference

7 January 2021

Comparison of sensory testing on different toe surfaces: implications for neuropathy screening

1 reference

7 January 2021

A comparison of the monofilament with other testing modalities for foot ulcer susceptibility

1 reference

7 January 2021

Measuring vibration sensations with graduated tuning fork. Simple and reliable means to detect diabetic patients at risk of neuropathic foot ulceration

1 reference

7 January 2021

The tuning fork revisited

1 reference

7 January 2021

The value of the Rydel-Seiffer tuning fork as a predictor of diabetic polyneuropathy compared with a neurothesiometer.

1 reference

7 January 2021

Impaired vibratory perception and diabetic foot ulceration

1 reference

7 January 2021

Measuring diabetic neuropathy. Assessment and comparison of clinical examination and quantitative sensory testing

1 reference

7 January 2021

Practical criteria for screening patients at high risk for diabetic foot ulceration.

1 reference

7 January 2021

Role of neuropathy and high foot pressures in diabetic foot ulceration.

1 reference

7 January 2021

Showing neuropathy is related to increased mortality in diabetic patients - a survival analysis using an accelerated failure time model

1 reference

7 January 2021

Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing: a case-control study

1 reference

7 January 2021

Predicted costs and outcomes from reduced vibration detection in people with diabetes in the U.S.

1 reference

7 January 2021

Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism

1 reference

7 January 2021

Protein kinase Cbeta selective inhibitor LY333531 attenuates diabetic hyperalgesia through ameliorating cGMP level of dorsal root ganglion neurons

1 reference

7 January 2021

Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial

1 reference

7 January 2021

Clinical potential of aldose reductase inhibitors in diabetic neuropathy

1 reference

7 January 2021

Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives

1 reference

7 January 2021

Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study

1 reference

7 January 2021

Diabetic neuropathies

1 reference

7 January 2021

Early detection of diabetic peripheral neuropathy with corneal confocal microscopy

1 reference

7 January 2021

The p75 neurotrophin receptor appears in plasma in diabetic rats-characterisation of a potential early test for neuropathy.

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.657

1 reference

14 August 2017

1 reference

PubMed ID

16741996